Электронный архив

Просмотр по теме "CAR T-cell therapy"

Просмотр по теме "CAR T-cell therapy"

Отсортировать по:Сортировать:Результаты поиска на странице:

  • Titov A.; Valiullina A.; Zmievskaya E.; Zaikova E.; Petukhov A.; Miftakhova R.; Bulatov E.; Rizvanov A. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Chimeric antigen receptor (CAR) immunotherapy is one of the most promising modern approaches for the treatment of cancer. To date only two CAR T-cell products, ...
  • Filin I.Y.; Solovyeva V.V.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this ...
  • Chulpanova D.S.; Kitaeva K.V.; Rutland C.S.; Rizvanov A.A.; Solovyeva V.V. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Recent advances in the development of new methods of cancer immunotherapy require the production of complex cancer animal models that reliably reflect the complexity ...

Поиск в электронном архиве

Просмотр

Моя учетная запись